Lite Strategy (LITS) Shares Issued (2011 - 2025)
Lite Strategy (LITS) posted quarterly Shares Issued of $869148.0 for Q2 2025, down 35.96% year-over-year from $1.4 million in Q2 2024, and up 433.22% quarter-over-quarter from $163001.0 in Q1 2025.
Lite Strategy (LITS) Shares Issued (2011 - 2025) Analysis & Trends
Lite Strategy's Shares Issued history runs 14 years deep, the most recent figure standing at $869148.0 for Q2 2025.
- In Q2 2025, Shares Issued fell 35.96% year-over-year to $869148.0; the TTM figure through Jun 2025 stood at $869148.0 (down 35.96% YoY), while the FY2025 annual figure was $869148.0, down 35.96% from the prior year.
- Shares Issued for Q2 2025 stood at $869148.0, up from $163001.0 in the prior quarter.
- The five-year high for Shares Issued was $1.4 billion in Q1 2024, with the low at $163001.0 in Q1 2025.
- The 5-year median for Shares Issued is $9.7 million (2021), against an average of $210.8 million.
- The sharpest annual moves came in 2023 and 2025: Shares Issued jumped 128816.12% in 2023, then tumbled 99.99% in 2025.
- Lite Strategy's Shares Issued stood at $27.4 million in 2021, then fell by 7.22% to $25.4 million in 2022, then surged by 3099.72% to $812.9 million in 2023, then slumped by 99.88% to $954723.0 in 2024, then decreased by 8.96% to $869148.0 in 2025.
- Business Quant data shows LITS's Shares Issued at $869148.0 in Q2 2025, $163001.0 in Q1 2025, and $954723.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Lite Strategy | 35.71 Mn | 28.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 869,148.00 |
| Jun 30, 2025 | 869,148.00 |
| Mar 31, 2025 | 163,001.00 |
| Mar 31, 2025 | 163,001.00 |
| Dec 31, 2024 | 954,723.00 |
| Dec 31, 2024 | 954,723.00 |
| Sep 30, 2024 | 1.12 Mn |
| Sep 30, 2024 | 1.12 Mn |
| Jun 30, 2024 | 1.36 Mn |
| Jun 30, 2024 | 1.36 Mn |
| Mar 31, 2024 | 1.37 Bn |
| Mar 31, 2024 | 1.37 Bn |
| Dec 31, 2023 | 812.88 Mn |
| Dec 31, 2023 | 812.88 Mn |
| Sep 30, 2023 | 1.45 Mn |
| Sep 30, 2023 | 1.45 Mn |
| Jun 30, 2023 | 1.28 Bn |
| Jun 30, 2023 | 1.28 Bn |
| Mar 31, 2023 | 1.25 Mn |
| Mar 31, 2023 | 1.25 Mn |